Phenotypic Tests Needed For HIV Drug Resistance Claims - FDA Committee
Executive Summary
HIV phenotypic testing will be necessary to prove that an antiretroviral drug is useful in treatment-resistant populations, FDA's Antiviral Drugs Advisory Committee suggested during its Nov. 2-3 meeting.